These findings are consistent with the research of Pickup et al., who demonstrated that type 2 diabetes is characterized by chronic low-grade inflammation, reflected by elevated acute-phase reactants and interleukin-6, contributing to metabolic dysfunction [31]. Here, IL6 is linked to type 2 diabetes mellitus.